CAS: 34976-39-1; 6-Ethyl-3-Methyl-2,9-Dioxo-[1,3]Thiazolo[5,4-F]Quinoline-8-Carboxylic Acid

结构式图片

MSDS等安全信息

    上下游产品

    f]quinoline-8-carboxylic acid methyl ester6-ethyl-3-methyl-2,9-dioxo-2,3,6,9-tetrahydro-thiazolo[5,4-f]quinoline-8-carboxylic acid methyl ester f]quinoline-8-carboxylic acid ethyl ester6-ethyl-3-methyl-2,9-dioxo-2,3,6,9-tetrahydro-thiazolo[5,4-f]quinoline-8-carboxylic acid ethyl ester f]quinolinium; methyl sulfate8-carboxy-6-ethyl-3-methyl-2-methylsulfanyl-9-oxo-6,9-dihydro-thiazolo[5,4-f]quinolinium; methyl sulfate f]quinoline-8-carboxylic acid ethyl ester6-ethyl-2-methylsulfanyl-9-oxo-6,9-dihydro-thiazolo[5,4-f]quinoline-8-carboxylic acid ethyl ester

    合成工艺路线路线简述

      海关参考信息

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Uekama K, Hirayama F, Takasugi N. [Soluble complex formation of 6-ethyl-2,3,6 ,9-tetrahydro-3-methyl-2,9-dioxothiazolo-[5,4-f]quinoline-8-carboxylic acid (tioxacin) with aliphatic amines (author's transl)]. Yakugaku Zasshi. 1979 May;99(5):476-82. Japanese. doi: 10.1248/yakushi1947.99.5_476.

      合成参考文献


      参考文献:10.1007/978-981-99-2302-1_24
      摘要:Singh R, Tandon V. Antibiotics: Past, Present, Future, and Clinical Pipeline. 2023. In: Recent Advances in Pharmaceutical Innovation and Research.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知